EDGAR Filing Documents for 0000950123-16-017103

Form DRS - Draft Registration Statement:

SEC Accession No. 0000950123-16-017103

Filing Date

2016-05-13

Accepted

2016-05-13 13:46:27

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	2439122
2	GRAPHIC	g183927g13v16.jpg	GRAPHIC	74854
3	GRAPHIC	g183927g17n95.jpg	GRAPHIC	51876
4	GRAPHIC	g183927g18j83.jpg	GRAPHIC	99604
5	GRAPHIC	g183927g18l30.jpg	GRAPHIC	67103
6	GRAPHIC	g183927g21w10.jpg	GRAPHIC	33374
7	GRAPHIC	g183927g22l44.jpg	GRAPHIC	121668
8	GRAPHIC	g183927g33r07.jpg	GRAPHIC	61125
9	GRAPHIC	g183927g84b16.jpg	GRAPHIC	34581
10	GRAPHIC	g183927g84i85.jpg	GRAPHIC	51063
11	GRAPHIC	g183927g90k59.jpg	GRAPHIC	44917
	Complete submission text file	0000950123-16-017103.txt		3317573

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600

CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
Type: DRS | Act: 33 | File No.: 377-01325 | Film No.: 161647437
SIC: 2836 Biological Products, (No Diagnostic Substances)